Analyst Ratings (USA)
Today’s analyst updates suggest a cautiously positive market outlook, with support for technology, financials, and selected consumer stocks. Downgrades in materials and parts of the automotive sector point to uneven confidence in cyclical industries. Overall, analysts favour selective opportunities, with earnings growth and valuation remaining central to the outlook.
Updates (469)
5E Advanced Materials (FEAM) — H.C. Wainwright maintained its Buy rating and raised its price target to $6.75 from $3.50.
Adtalem Global Education (CVSA) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $145.00 from $148.00.
Advanced Micro Devices (AMD) — Cantor Fitzgerald maintained its Overweight rating.
Advanced Micro Devices (AMD) — Stifel maintained its Buy rating and raised its price target to $700.00 from $635.00.
AECOM (ACM) — Truist Securities maintained its Buy rating and lowered its price target to $75.00 from $85.00.
Aercap (AER) — Truist Securities set a price target of $180.00.
Aether (ATHR) — Ascendiant Capital Markets initiated coverage with a Buy rating and a $10.00 price target.
AGCO (AGCO) — Truist Securities maintained its Buy rating and raised its price target to $146.00 from $135.00.
Agenus (AGEN) — Chardan Capital maintained its Buy rating with a $40.00 price target.
Air Products and Chemicals (APD) — UBS maintained its Neutral rating and lowered its price target to $305.00 from $336.00.
Albemarle (ALB) — UBS maintained its Buy rating and lowered its price target to $150.00 from $175.00.
Align Technology (ALGN) — Evercore ISI downgraded its rating to In-Line from Outperform with a $155.00 price target.
Align Technology (ALGN) — Raymond James maintained its Buy rating.
Ally Financial (ALLY) — UBS maintained its Buy rating and lowered its price target to $50.00 from $54.00.
Alpha and Omega Semiconductor (AOSL) — Stifel maintained its Hold rating and lowered its price target to $34.00 from $38.00.
Alumis (ALMS) — Benchmark maintained its Buy rating.
Alumis (ALMS) — H.C. Wainwright maintained its Buy rating.
Amazon.com (AMZN) — Cantor Fitzgerald maintained its Overweight rating.
Amazon.com (AMZN) — TD Cowen maintained its Buy rating with a $350.00 price target.
Ambiq Micro (AMBQ) — Stifel maintained its Buy rating and raised its price target to $85.00 from $75.00.
American Express (AXP) — Barclays maintained its Equal Weight rating and lowered its price target to $342.00 from $364.00.
American Express (AXP) — UBS maintained its Neutral rating and lowered its price target to $345.00 from $384.00.
Ameriprise Financial (AMP) — BofA Securities maintained its Buy rating with a $570.00 price target.
AMETEK (AME) — Baird maintained its Neutral rating and raised its price target to $280.00 from $275.00.
Amgen (AMGN) — Cantor Fitzgerald maintained its Neutral rating.
Amrize (AMRZ) — Truist Securities maintained its Hold rating and lowered its price target to $35.00 from $48.00.
Amrize (AMRZ) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $40.00 from $44.00.
Anheuser-Busch InBev SA/NV (BUD) — Wells Fargo maintained its Overweight rating and lowered its price target to $88.00 from $97.00.
Antero Resources (AR) — Truist Securities maintained its Buy rating and lowered its price target to $46.00 from $52.00.
Applied Aerospace & Defense (AADX) — Jefferies set a price target of $20.00.
ArcelorMittal (MT) — Deutsche Bank set a price target of $79.00.
Ardagh Metal Packaging (AMBP) — UBS maintained its Neutral rating and lowered its price target to $4.50 from $5.00.
Asbury Automotive Group (ABG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $184.00 from $230.00.
Ashland (ASH) — UBS maintained its Buy rating and lowered its price target to $80.00 from $83.00.
Associated Banc (ASB) — Barclays maintained its Overweight rating and raised its price target to $35.00 from $34.00.
AST SpaceMobile (ASTS) — William Blair maintained its Market Perform rating.
Atlantic Union Bankshares (AUB) — TD Cowen maintained its Buy rating and lowered its price target to $44.00 from $48.00.
Atlas Energy Solutions (AESI) — Stephens maintained its Overweight rating and lowered its price target to $20.00 from $22.00.
AutoNation (AN) — Morgan Stanley downgraded its rating to Equal Weight from Overweight and lowered its price target to $175.00 from $250.00.
Avidia Bancorp (AVBC) — Hovde Group initiated coverage with an Outperform rating and a $26.00 price target.
Axalta Coating Systems (AXTA) — KeyBanc Capital Markets maintained its Overweight rating.
Axalta Coating Systems (AXTA) — UBS maintained its Neutral rating and lowered its price target to $36.00 from $39.00.
AxoGen (AXGN) — Lake Street Capital maintained its Buy rating.
Axos Financial (AX) — Needham maintained its Buy rating with a $128.00 price target.
Ball (BALL) — UBS maintained its Neutral rating and lowered its price target to $63.00 from $66.00.
Banc of California (BANC) — Barclays maintained its Overweight rating and raised its price target to $23.00 from $22.00.
Bank of America (BAC) — UBS maintained its Buy rating and lowered its price target to $67.00 from $70.00.
Bank of New York Mellon (BNY) — Citigroup maintained its Neutral rating and lowered its price target to $160.00 from $172.00.
Bank OZK (OZK) — TD Cowen maintained its Hold rating and lowered its price target to $50.00 from $52.00.
Baxter International (BAX) — Citigroup maintained its Neutral rating and lowered its price target to $27.00 from $28.00.
BETA Technologies (BETA) — Cantor Fitzgerald maintained its Overweight rating with a $31.00 price target.
Boston Scientific (BSX) — Citigroup maintained its Neutral rating and lowered its price target to $48.00 from $50.00.
BP (BP) — Barclays maintained its Overweight rating.
BP (BP) — Evercore ISI upgraded its rating to Outperform.
BP (BP) — Mizuho maintained its Outperform rating and raised its price target to $56.00 from $53.00.
Braze (BRZE) — Citigroup maintained its Market Outperform rating.
Braze (BRZE) — Citizens maintained its Market Outperform rating with a $35.00 price target.
Bread Financial (BFH) — Barclays maintained its Equal Weight rating and raised its price target to $110.00 from $109.00.
BridgeBio Pharma (BBIO) — Cantor Fitzgerald maintained its Overweight rating.
BridgeBio Pharma (BBIO) — Jefferies maintained its Buy rating.
BridgeBio Pharma (BBIO) — TD Cowen maintained its Buy rating.
Bright Horizons Family Solutions (BFAM) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $83.00 from $93.00.
BrightSpire Capital (BRSP) — Barclays maintained its Underweight rating and lowered its price target to $4.00 from $6.00.
Bristol Myers Squibb (BMY) — Leerink Partners downgraded its rating to Market Perform from Outperform and lowered its price target to $59.00 from $73.00.
Brookfield Asset Management (BAM) — BofA Securities maintained its Neutral rating and lowered its price target to $60.00 from $61.00.
C.H. Robinson Worldwide (CHRW) — JPMorgan maintained its Overweight rating and lowered its price target to $198.00 from $225.00.
Cabot (CBT) — UBS maintained its Neutral rating and lowered its price target to $86.00 from $92.00.
CAMP4 Therapeutics (CAMP) — Oppenheimer initiated coverage with an Outperform rating and a $15.00 price target.
Camping World (CWH) — Raymond James maintained its Outperform rating.
Capital One Financial (COF) — Barclays maintained its Overweight rating and lowered its price target to $237.00 from $240.00.
CareTrust REIT (CTRE) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $45.00 from $47.00.
CareTrust REIT (CTRE) — Raymond James maintained its Outperform rating and lowered its price target to $42.00 from $45.00.
CareTrust REIT (CTRE) — RBC Capital Markets maintained its Sector Perform rating with a $43.00 price target.
Carlyle Group (CG) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $48.00 from $58.00.
Caterpillar (CAT) — Truist Securities maintained its Buy rating and lowered its price target to $1,100.00 from $1,225.00.
Cboe Global Markets (CBOE) — TD Cowen upgraded its rating to Buy from Hold with a $334.00 price target.
Cerebras Systems (CBRS) — Jefferies upgraded its rating to Outperform.
CervoMed (CRVO) — H.C. Wainwright maintained its Buy rating.
CF Industries (CF) — RBC Capital Markets maintained its Sector Perform rating with a $115.00 price target.
Charles Schwab (SCHW) — BofA Securities maintained its Underperform rating and raised its price target to $95.00 from $91.00.
Chemours (CC) — UBS maintained its Neutral rating and lowered its price target to $16.00 from $18.00.
Chord Energy (CHRD) — Mizuho maintained its Outperform rating and raised its price target to $179.00 from $175.00.
Church & Dwight (CHD) — Wells Fargo maintained its Overweight rating and lowered its price target to $105.00 from $110.00.
Citizens (CIZN) — Citigroup downgraded its rating to Market Perform from Market Outperform.
Citizens Financial Group (CFG) — UBS set a price target of $77.00.
Climb Bio (CLYM) — Raymond James maintained its Strong-Buy rating with a $34.00 price target.
Clorox (CLX) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $85.00 from $90.00.
Cloudflare (NET) — Cantor Fitzgerald maintained its Neutral rating with a $340.00 price target.
CME Group (CME) — TD Cowen maintained its Buy rating and raised its price target to $300.00 from $292.00.
CME Group (CME) — UBS maintained its Neutral rating and raised its price target to $270.00 from $260.00.
CNH Industrial (CNH) — Truist Securities maintained its Buy rating and raised its price target to $17.00 from $15.00.
Coca-Cola Europacific Partners (CCEP) — UBS maintained its Neutral rating.
Coca-Cola Europacific Partners (CCEP) — Wells Fargo maintained its Overweight rating and lowered its price target to $115.00 from $120.00.
CocaCola (KO) — Wells Fargo maintained its Overweight rating and lowered its price target to $90.00 from $95.00.
Cognex (CGNX) — Truist Securities maintained its Hold rating and lowered its price target to $74.00 from $78.00.
Cognition Therapeutics (CGTX) — H.C. Wainwright maintained its Buy rating.
Coinbase Global (COIN) — BofA Securities maintained its Buy rating.
Colgate-Palmolive (CL) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $90.00 from $95.00.
Columbia Banking System (COLB) — Barclays maintained its Equal Weight rating and raised its price target to $32.00 from $30.00.
Columbia Banking System (COLB) — TD Cowen maintained its Hold rating and lowered its price target to $32.00 from $34.00.
Commerce Bancshares (CBSH) — Piper Sandler maintained its Neutral rating and lowered its price target to $63.00 from $66.00.
CommVault Systems (CVLT) — Scotiabank maintained its Sector Perform rating and raised its price target to $160.00 from $130.00.
Constellation Brands (STZ) — Wells Fargo maintained its Overweight rating and lowered its price target to $140.00 from $170.00.
Corning (GLW) — UBS maintained its Buy rating and raised its price target to $201.00 from $196.00.
Corteva (CTVA) — New Street Research set a price target of $17.00.
Corteva (CTVA) — Oppenheimer set a price target of $17.00.
Coursera (COUR) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $6.00 from $8.00.
Covenant Logistics Group (CVLG) — TD Cowen maintained its Buy rating and lowered its price target to $42.00 from $43.00.
Credo Technology Group (CRDO) — Stifel maintained its Buy rating and lowered its price target to $310.00 from $350.00.
CRH (CRH) — Truist Securities maintained its Buy rating and lowered its price target to $105.00 from $130.00.
CRH (CRH) — Wells Fargo maintained its Overweight rating and lowered its price target to $106.00 from $107.00.
Critical Metals (CRML) — UBS set a price target of $20.00.
Crown (CCK) — UBS maintained its Neutral rating and lowered its price target to $116.00 from $123.00.
CSX (CSX) — JPMorgan maintained its Overweight rating and lowered its price target to $57.00 from $58.00.
Cullen/Frost Bankers (CFR) — Barclays maintained its Equal Weight rating and raised its price target to $175.00 from $160.00.
Cullen/Frost Bankers (CFR) — TD Cowen maintained its Buy rating and lowered its price target to $178.00 from $185.00.
Cummins (CMI) — Truist Securities maintained its Buy rating and lowered its price target to $779.00 from $894.00.
Customers Bancorp (CUBI) — TD Cowen maintained its Buy rating and lowered its price target to $91.00 from $94.00.
Cyclerion Therapeutics (KRSA) — Wedbush initiated coverage with an Outperform rating and a $44.00 price target.
Danaher (DHR) — RBC Capital Markets maintained its Outperform rating and raised its price target to $250.00 from $215.00.
Domino’s Pizza (DPZ) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $325.00 from $350.00.
Domino’s Pizza (DPZ) — UBS maintained its Buy rating.
DoorDash (DASH) — Wells Fargo maintained its Cautious rating and raised its price target to $230.00 from $225.00.
DraftKings (DKNG) — BofA Securities upgraded its rating to Buy from Neutral with a $27.00 price target.
DTE Energy (DTE) — BMO Capital Markets maintained its Market Perform rating and raised its price target to $134.00 from $132.00.
DuPont de Nemours (DD) — UBS maintained its Buy rating and lowered its price target to $172.00 from $178.00.
Eagle Materials (EXP) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $188.00 from $196.00.
Eastern Bankshares (EBC) — Barclays maintained its Equal Weight rating and raised its price target to $23.00 from $22.00.
Eastern Bankshares (EBC) — TD Cowen maintained its Buy rating and lowered its price target to $25.00 from $26.00.
Eastman Chemical (EMN) — UBS maintained its Buy rating and lowered its price target to $77.00 from $92.00.
Ecolab (ECL) — UBS maintained its Buy rating and raised its price target to $344.00 from $342.00.
Edgewell Personal Care (EPC) — Wells Fargo maintained its Overweight rating and lowered its price target to $30.00 from $32.00.
Edwards Lifesciences (EW) — Citigroup maintained its Buy rating.
Elbit Systems (ESLT) — Jefferies maintained its Hold rating with a $790.00 price target.
Element Solutions (ESI) — UBS maintained its Buy rating and raised its price target to $48.00 from $47.00.
ENI (E) — Barclays maintained its Overweight rating.
Enovis (ENOV) — UBS maintained its Buy rating with a $44.00 price target.
Enphase Energy (ENPH) — Oppenheimer maintained its Outperform rating with a $55.00 price target.
EquipmentShare.com (EQPT) — Truist Securities maintained its Buy rating and lowered its price target to $31.00 from $35.00.
Ermenegildo Zegna (ZGN) — UBS maintained its Buy rating and lowered its price target to $15.40 from $15.50.
Essent Group (ESNT) — Barclays maintained its Equal Weight rating and raised its price target to $66.00 from $65.00.
Estee Lauder Companies (EL) — Barclays upgraded its rating to Overweight from Equal Weight and raised its price target to $108.00 from $97.00.
Estee Lauder Companies (EL) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $95.00 from $104.00.
eToro Group (ETOR) — BofA Securities maintained its Neutral rating.
Expand Energy (EXE) — Raymond James maintained its Strong-Buy rating and lowered its price target to $141.00 from $147.00.
Expand Energy (EXE) — Sanford C. Bernstein maintained its Outperform rating and lowered its price target to $127.00 from $160.00.
Expand Energy (EXE) — Truist Securities maintained its Buy rating and lowered its price target to $120.00 from $121.00.
Expeditors International of Washington (EXPD) — JPMorgan maintained its Neutral rating and raised its price target to $214.00 from $200.00.
Federal Realty Investment Trust (FRT) — Wells Fargo maintained its Overweight rating and lowered its price target to $126.00 from $134.00.
FedEx (FDX) — JPMorgan maintained its Overweight rating and lowered its price target to $399.00 from $400.00.
FedEx Freight (FDXF) — JPMorgan maintained its Overweight rating and lowered its price target to $149.00 from $160.00.
Ferrari (RACE) — UBS maintained its Buy rating and lowered its price target to $450.00 from $490.00.
Fidelity National Financial (FNF) — Barclays maintained its Equal Weight rating and lowered its price target to $47.00 from $54.00.
Fifth Third Bancorp (FITB) — UBS set a price target of $63.00.
Figure Technology Solutions (FIGR) — BofA Securities maintained its Neutral rating with a $44.00 price target.
First American Financial (FAF) — Barclays maintained its Overweight rating and lowered its price target to $79.00 from $83.00.
First Hawaiian (FHB) — TD Cowen maintained its Hold rating and lowered its price target to $28.00 from $31.00.
First Interstate BancSystem (FIBK) — Barclays maintained its Underweight rating and raised its price target to $38.00 from $37.00.
First Merchants (FRME) — Piper Sandler maintained its Overweight rating and lowered its price target to $46.00 from $51.00.
Flagstar Bank, National Association (FLG) — Barclays maintained its Overweight rating and lowered its price target to $15.00 from $17.00.
Flagstar Bank, National Association (FLG) — TD Cowen maintained its Buy rating and lowered its price target to $16.00 from $17.00.
FMC (FMC) — UBS maintained its Neutral rating and lowered its price target to $10.00 from $12.00.
Forbright (FRBT) — Barclays maintained its Overweight rating and raised its price target to $24.00 from $23.00.
FormFactor (FORM) — Freedom Capital Markets maintained its Hold rating and raised its price target to $140.00 from $64.00.
Fortive (FTV) — Truist Securities maintained its Hold rating and lowered its price target to $63.00 from $68.00.
Freeport-McMoRan (FCX) — Citigroup maintained its Buy rating and raised its price target to $84.00 from $66.00.
Freshpet (FRPT) — Piper Sandler maintained its Overweight rating.
Freshpet (FRPT) — Wells Fargo maintained its Overweight rating and lowered its price target to $77.00 from $82.00.
Gain Therapeutics (GANX) — BTIG maintained its Buy rating with a $5.00 price target.
Gain Therapeutics (GANX) — H.C. Wainwright maintained its Buy rating with a $8.00 price target.
Gartner (IT) — UBS maintained its Neutral rating and raised its price target to $208.00 from $196.00.
GE HealthCare Technologies (GEHC) — Citigroup maintained its Neutral rating and lowered its price target to $71.00 from $75.00.
GE HealthCare Technologies (GEHC) — Needham maintained its Buy rating with a $93.00 price target.
GE HealthCare Technologies (GEHC) — RBC Capital Markets maintained its Outperform rating.
Generac (GNRC) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $297.00 from $333.00.
Generate Biomedicines (GENB) — H.C. Wainwright maintained its Buy rating with a $30.00 price target.
Genmab A/S (GMAB) — Guggenheim maintained its Buy rating and raised its price target to $54.00 from $45.00.
GlobalFoundries (GFS) — BNP Paribas Exane downgraded its rating to Neutral from Outperform with a $51.00 price target.
Globe Life (GL) — Morgan Stanley maintained its Overweight rating and lowered its price target to $197.00 from $208.00.
Grand Canyon Education (LOPE) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $182.00 from $185.00.
Graphic Packaging (GPK) — UBS maintained its Neutral rating and lowered its price target to $9.50 from $12.00.
Group 1 Automotive (GPI) — Morgan Stanley downgraded its rating to Underweight from Equal Weight and lowered its price target to $232.00 from $300.00.
Grupo Aeroportuario Del Pacifico (PAC) — HSBC upgraded its rating to Buy from Hold with a $277.00 price target.
Grupo Aeroportuario Del Pacifico (PAC) — HSBC Securities upgraded its rating to Buy from Hold with a $277.00 price target.
Hancock Whitney (HWC) — Barclays maintained its Overweight rating and raised its price target to $85.00 from $82.00.
Harley-Davidson (HOG) — Citigroup upgraded its rating to Buy from Neutral and raised its price target to $33.00 from $31.00.
Harley-Davidson (HOG) — Evercore ISI upgraded its rating to Outperform from Underperform with a $33.00 price target.
Helmerich & Payne (HP) — Susquehanna maintained its Positive rating and raised its price target to $50.00 from $44.00.
Hermes International (HESAY) — Goldman Sachs initiated coverage with a Sell rating.
Hermes International (HESAY) — UBS downgraded its rating to Sell from Neutral.
Hershey (HSY) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $170.00 from $190.00.
HF Sinclair (DINO) — UBS maintained its Buy rating and raised its price target to $133.00 from $126.00.
Hub Group (HUBG) — JPMorgan maintained its Neutral rating and lowered its price target to $46.00 from $50.00.
HubSpot (HUBS) — Raymond James downgraded its rating to Market Perform from Outperform.
HubSpot (HUBS) — UBS downgraded its rating to Market Perform from Sector Perform.
Huntington Bancshares (HBAN) — UBS maintained its Buy rating and lowered its price target to $19.00 from $22.00.
Huntsman (HUN) — UBS maintained its Neutral rating and lowered its price target to $9.00 from $10.00.
Illinois Tool Works (ITW) — Truist Securities maintained its Hold rating and lowered its price target to $297.00 from $308.00.
Illumina (ILMN) — RBC Capital Markets maintained its Outperform rating and raised its price target to $310.00 from $230.00.
Incyte (INCY) — Stifel maintained its Buy rating and raised its price target to $157.00 from $145.00.
Incyte (INCY) — UBS maintained its Neutral rating with a $127.00 price target.
Ingredion (INGR) — UBS maintained its Neutral rating and lowered its price target to $104.00 from $108.00.
Integra LifeSciences (IART) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $15.00 from $18.00.
Integra LifeSciences (IART) — Citigroup maintained its Neutral rating and lowered its price target to $15.00 from $19.00.
Interactive Brokers Group (IBKR) — BofA Securities maintained its Buy rating and raised its price target to $116.00 from $114.00.
Intercontinental Exchange (ICE) — TD Cowen downgraded its rating to Hold from Buy and lowered its price target to $166.00 from $177.00.
International Paper (IP) — UBS maintained its Neutral rating and lowered its price target to $35.00 from $47.00.
International Seaways (INSW) — B. Riley Financial maintained its Buy rating and raised its price target to $140.00 from $120.00.
iRhythm Technologies (IRTC) — Needham maintained its Buy rating and raised its price target to $194.00 from $192.00.
ITG (ITG) — Truist Securities maintained its Buy rating and lowered its price target to $14.00 from $17.00.
J.B. Hunt Transport Services (JBHT) — JPMorgan maintained its Overweight rating and lowered its price target to $287.00 from $313.00.
J.B. Hunt Transport Services (JBHT) — TD Cowen maintained its Hold rating and lowered its price target to $283.00 from $297.00.
J.Jill (JILL) — TD Cowen maintained its Hold rating and raised its price target to $25.00 from $22.00.
Jacobs Solutions (J) — Truist Securities maintained its Hold rating and lowered its price target to $160.00 from $161.00.
Johnson & Johnson (JNJ) — Citigroup maintained its Buy rating and raised its price target to $303.00 from $298.00.
JPMorgan Chase & Co. (JPM) — UBS maintained its Buy rating and lowered its price target to $395.00 from $400.00.
KB Home (KBH) — Keefe Bruyette & Woods maintained its Market Perform rating and lowered its price target to $54.00 from $65.00.
KeyCorp (KEY) — UBS maintained its Buy rating and lowered its price target to $25.00 from $27.00.
Kimberly-Clark (KMB) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $100.00 from $105.00.
KinderCare Learning Companies (KLC) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $4.00 from $5.00.
Knife River (KNF) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $54.00 from $62.00.
Knight-Swift Transportation (KNX) — JPMorgan maintained its Neutral rating and lowered its price target to $68.00 from $84.00.
Kodiak Gas Services (KGS) — Barclays maintained its Overweight rating and lowered its price target to $67.00 from $72.00.
Kraft Heinz (KHC) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $23.00 from $25.00.
Kura Oncology (KURA) — UBS maintained its Buy rating.
Kymera Therapeutics (KYMR) — Citigroup maintained its Buy rating and raised its price target to $150.00 from $135.00.
Lam Research (LRCX) — Morgan Stanley maintained its Overweight rating and raised its price target to $385.00 from $367.00.
Lamb Weston (LW) — Wells Fargo maintained its Overweight rating and lowered its price target to $54.00 from $57.00.
Landstar System (LSTR) — JPMorgan maintained its Neutral rating and lowered its price target to $181.00 from $204.00.
LB Pharmaceuticals (LBRX) — Guggenheim initiated coverage with a Buy rating and a $80.00 price target.
LB Pharmaceuticals (LBRX) — Roth Capital downgraded its rating to Neutral from Buy and lowered its price target to $35.00 from $37.00.
LifeStance Health Group (LFST) — KeyBanc Capital Markets maintained its Overweight rating and raised its price target to $15.00 from $13.00.
Lincoln National (LNC) — Morgan Stanley maintained its Overweight rating and lowered its price target to $47.00 from $50.00.
Linde (LIN) — Sanford C. Bernstein maintained its Outperform rating.
Linde (LIN) — UBS maintained its Buy rating and lowered its price target to $574.00 from $612.00.
Lithia Motors (LAD) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $310.00 from $358.00.
Live Oak Bancshares (LOB) — TD Cowen maintained its Buy rating and lowered its price target to $44.00 from $49.00.
LPL Financial (LPLA) — BofA Securities maintained its Buy rating and lowered its price target to $554.00 from $557.00.
LPL Financial (LPLA) — Citigroup maintained its Market Outperform rating.
LPL Financial (LPLA) — Citizens maintained its Market Outperform rating with a $500.00 price target.
Lsb Industries (LXU) — RBC Capital Markets maintained its Outperform rating with a $13.00 price target.
Lumentum (LITE) — Rosenblatt maintained its Buy rating with a $1,300.00 price target.
Lumentum (LITE) — Stifel maintained its Buy rating and raised its price target to $1,232.00 from $1,100.00.
Lumexa Imaging (LMRI) — Truist Securities initiated coverage with a Buy rating and a $18.00 price target.
Lyft (LYFT) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $17.00 from $19.00.
M&T Bank (MTB) — UBS maintained its Neutral rating and lowered its price target to $238.00 from $255.00.
Maplebear (CART) — Wells Fargo maintained its Equal Weight rating and raised its price target to $56.00 from $54.00.
Maplight Therapeutics (MPLT) — Guggenheim initiated coverage with a Neutral rating.
Maravai LifeSciences (MRVI) — TD Cowen initiated coverage with a Buy rating and a $9.00 price target.
Martin Marietta Materials (MLM) — Truist Securities maintained its Buy rating and lowered its price target to $625.00 from $730.00.
Martin Marietta Materials (MLM) — Wells Fargo maintained its Overweight rating and lowered its price target to $579.00 from $585.00.
MasTec (MTZ) — TD Cowen maintained its Buy rating and lowered its price target to $320.00 from $420.00.
MasTec (MTZ) — Truist Securities maintained its Buy rating and lowered its price target to $380.00 from $428.00.
McDonald’s (MCD) — Guggenheim maintained its Neutral rating and lowered its price target to $250.00 from $290.00.
McDonald’s (MCD) — Wells Fargo maintained its Overweight rating and lowered its price target to $270.00 from $300.00.
Merchants Bancorp (MBIN) — Piper Sandler maintained its Overweight rating and lowered its price target to $63.00 from $64.00.
Merck & Co., Inc. (MRK) — JPMorgan maintained its Overweight rating and raised its price target to $165.00 from $150.00.
Methanex (MEOH) — UBS maintained its Buy rating and raised its price target to $74.00 from $71.00.
MetLife (MET) — TD Cowen maintained its Buy rating and raised its price target to $110.00 from $105.00.
MGIC Investment (MTG) — Barclays maintained its Equal Weight rating and raised its price target to $29.00 from $28.00.
MGP Ingredients (MGPI) — Wells Fargo maintained its Overweight rating and lowered its price target to $17.00 from $22.00.
Microsoft (MSFT) — Melius Research upgraded its rating to Buy from Hold with a $665.00 price target.
Microsoft (MSFT) — Scotiabank maintained its Sector Outperform rating and raised its price target to $615.00 from $510.00.
Millrose Properties (MRP) — Citizens downgraded its rating to Market Perform from Market Outperform.
Molson Coors Beverage (TAP) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $38.00 from $41.00.
Mondelez International (MDLZ) — Wells Fargo maintained its Overweight rating and lowered its price target to $65.00 from $70.00.
Monolithic Power Systems (MPWR) — TD Cowen maintained its Buy rating.
Monster Beverage (MNST) — Wells Fargo maintained its Overweight rating and lowered its price target to $48.00 from $53.00.
Monte Rosa Therapeutics (GLUE) — Benchmark maintained its Buy rating.
Monte Rosa Therapeutics (GLUE) — Raymond James set a price target of $25.00.
MoonLake Immunotherapeutics (MLTX) — H.C. Wainwright maintained its Buy rating with a $50.00 price target.
Morgan Stanley (MS) — UBS maintained its Buy rating and lowered its price target to $236.00 from $260.00.
Mosaic (MOS) — RBC Capital Markets downgraded its rating to Sector Perform from Outperform and lowered its price target to $25.00 from $27.00.
Nabors Industries (NBR) — Susquehanna maintained its Neutral rating and raised its price target to $91.00 from $85.00.
National Bank (NBHC) — DA Davidson maintained its Buy rating and lowered its price target to $43.00 from $45.00.
Navient (NAVI) — Barclays maintained its Underweight rating and lowered its price target to $7.00 from $8.00.
Netflix (NFLX) — TD Cowen maintained its Buy rating with a $100.00 price target.
NETGEAR (NTGR) — Stifel maintained its Buy rating and lowered its price target to $30.00 from $36.00.
NewAmsterdam Pharma (NAMS) — RBC Capital Markets maintained its Outperform rating and lowered its price target to $42.00 from $50.00.
NIKE (NKE) — Barclays maintained its Overweight rating and lowered its price target to $37.00 from $48.00.
Noble (NE) — Susquehanna maintained its Neutral rating and raised its price target to $44.00 from $40.00.
Nordic American Tankers (NAT) — B. Riley Financial maintained its Buy rating and raised its price target to $10.00 from $8.00.
Norfolk Southern (NSC) — JPMorgan maintained its Neutral rating and lowered its price target to $318.00 from $338.00.
Northern Trust (NTRS) — Citigroup maintained its Neutral rating and raised its price target to $186.00 from $182.00.
Nucor (NUE) — KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to $286.00 from $288.00.
Nutrien (NTR) — RBC Capital Markets maintained its Outperform rating with a $85.00 price target.
nVent Electric (NVT) — BMO Capital Markets initiated coverage with an Outperform rating and a $212.00 price target.
NVIDIA (NVDA) — BNP Paribas Exane maintained its Outperform rating with a $345.00 price target.
NXP Semiconductors (NXPI) — Stifel maintained its Hold rating and lowered its price target to $265.00 from $282.00.
O-I Glass (OI) — UBS downgraded its rating to Neutral from Buy and lowered its price target to $6.00 from $11.00.
Oil States International (OIS) — Susquehanna maintained its Neutral rating and raised its price target to $9.00 from $8.00.
Okeanis Eco Tankers (ECO) — B. Riley Financial maintained its Buy rating and raised its price target to $100.00 from $75.00.
Old Dominion Freight Line (ODFL) — JPMorgan maintained its Neutral rating and lowered its price target to $232.00 from $250.00.
Old National Bancorp (ONB) — TD Cowen maintained its Buy rating and lowered its price target to $30.00 from $31.00.
Olin (OLN) — UBS maintained its Neutral rating and lowered its price target to $18.00 from $21.00.
Ondas (ONDS) — Citigroup initiated coverage with a Market Outperform rating.
Ondas (ONDS) — Citizens initiated coverage with a Market Outperform rating and a $14.00 price target.
onsemi (ON) — Stifel maintained its Hold rating and raised its price target to $80.00 from $75.00.
Orchestra BioMed (OBIO) — H.C. Wainwright maintained its Buy rating with a $10.00 price target.
Oric Pharmaceuticals (ORIC) — Leerink Partners initiated coverage with an Outperform rating and a $26.00 price target.
Orion (OEC) — UBS maintained its Neutral rating and lowered its price target to $6.50 from $8.00.
Oshkosh (OSK) — Truist Securities maintained its Buy rating and lowered its price target to $174.00 from $196.00.
Ovid Therapeutics (OVID) — Guggenheim initiated coverage with a Buy rating and a $7.00 price target.
Oxford Industries (OXM) — BTIG maintained its Neutral rating.
PACCAR (PCAR) — Truist Securities maintained its Hold rating and lowered its price target to $125.00 from $139.00.
Packaging Corporation of America (PKG) — UBS maintained its Buy rating and lowered its price target to $289.00 from $292.00.
PBF Energy (PBF) — UBS maintained its Buy rating with a $99.00 price target.
PennyMac Financial Services (PFSI) — Barclays maintained its Equal Weight rating and lowered its price target to $71.00 from $85.00.
Peoples Bancorp (PEBO) — Keefe Bruyette & Woods maintained its Market Perform rating.
Peoples Bancorp (PEBO) — Piper Sandler set a price target of $42.00.
PepsiCo (PEP) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $135.00 from $140.00.
Pershing Square (PS) — RBC Capital Markets maintained its Sector Perform rating and raised its price target to $44.00 from $41.00.
Phillips Edison & Company, Inc. (PECO) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $41.00 from $43.00.
Phoenix Education Partners (PXED) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $33.00 from $36.00.
Pinnacle Financial Partners (PNFP) — TD Cowen maintained its Buy rating and lowered its price target to $115.00 from $119.00.
Pinnacle West Capital (PNW) — Jefferies maintained its Buy rating and lowered its price target to $109.00 from $129.00.
Pinnacle West Capital (PNW) — Truist Securities maintained its Hold rating and lowered its price target to $99.00 from $101.00.
Planet Fitness (PLNT) — Baird maintained its Outperform rating and lowered its price target to $60.00 from $72.00.
Planet Fitness (PLNT) — RBC Capital Markets maintained its Outperform rating and lowered its price target to $60.00 from $65.00.
Popular (BPOP) — Barclays maintained its Overweight rating and raised its price target to $205.00 from $200.00.
Post (POST) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $79.00 from $86.00.
Power Integrations (POWI) — Stifel maintained its Buy rating and lowered its price target to $72.00 from $80.00.
PPG Industries (PPG) — UBS maintained its Neutral rating and lowered its price target to $116.00 from $125.00.
Procore Technologies (PCOR) — Cantor Fitzgerald maintained its Overweight rating with a $65.00 price target.
Progressive (PGR) — JPMorgan maintained its Neutral rating and raised its price target to $250.00 from $241.00.
Prosperity Bancshares (PB) — Barclays maintained its Underweight rating and raised its price target to $70.00 from $68.00.
Prosperity Bancshares (PB) — TD Cowen maintained its Buy rating and lowered its price target to $78.00 from $84.00.
PTC (PTC) — Barclays downgraded its rating to Equal Weight from Overweight with a $205.00 price target.
PTC (PTC) — Deutsche Bank downgraded its rating to Hold with a $205.00 price target.
PTC (PTC) — KeyBanc Capital Markets downgraded its rating to Sector Weight from Overweight.
PTC (PTC) — Loop Capital downgraded its rating to Hold from Buy and raised its price target to $205.00 from $200.00.
PTC (PTC) — RBC Capital Markets downgraded its rating to Sector Perform from Buy and raised its price target to $306.00 from $195.00.
PTC (PTC) — Rosenblatt downgraded its rating to Neutral from Buy with a $205.00 price target.
PTC (PTC) — Stifel set a price target of $205.00.
QT Imaging (QTI) — Craig-Hallum initiated coverage with a Buy rating and a $8.00 price target.
Quanta Services (PWR) — Cantor Fitzgerald maintained its Overweight rating with a $862.00 price target.
Quanta Services (PWR) — Truist Securities maintained its Buy rating and lowered its price target to $945.00 from $976.00.
Radian Group (RDN) — Barclays maintained its Equal Weight rating and raised its price target to $36.00 from $35.00.
Range Resources (RRC) — BMO Capital Markets maintained its Market Perform rating.
Range Resources (RRC) — Truist Securities maintained its Hold rating and lowered its price target to $43.00 from $45.00.
Rapport Therapeutics (RAPP) — Guggenheim maintained its Buy rating with a $65.00 price target.
Raymond James Financial (RJF) — BofA Securities maintained its Neutral rating and raised its price target to $198.00 from $196.00.
Raymond James Financial (RJF) — JPMorgan maintained its Neutral rating and raised its price target to $185.00 from $179.00.
Rayonier (RYN) — Citigroup maintained its Neutral rating and lowered its price target to $19.00 from $23.00.
Regency Centers (REG) — Morgan Stanley maintained its Overweight rating and lowered its price target to $87.00 from $88.00.
REGENXBIO (RGNX) — Mizuho initiated coverage with an Outperform rating and a $22.00 price target.
Regions Financial (RF) — UBS maintained its Neutral rating and lowered its price target to $30.00 from $33.00.
Reliance (RS) — KeyBanc Capital Markets maintained its Overweight rating and raised its price target to $421.00 from $418.00.
Renasant (RNST) — TD Cowen maintained its Buy rating and lowered its price target to $46.00 from $49.00.
Rentokil Initial (RTO) — Goldman Sachs maintained its Buy rating.
Rentokil Initial (RTO) — Stifel upgraded its rating to Buy from Hold.
Replimune Group (REPL) — Cantor Fitzgerald maintained its Overweight rating.
Revvity (RVTY) — William Blair initiated coverage with an Outperform rating.
Rezolute (RZLT) — Cantor Fitzgerald upgraded its rating to Overweight from Neutral.
Robinhood Markets (HOOD) — BofA Securities maintained its Buy rating and raised its price target to $156.00 from $140.00.
Robinhood Markets (HOOD) — Raymond James maintained its Market Perform rating.
Rocket Companies (RKT) — Barclays maintained its Overweight rating and lowered its price target to $15.00 from $17.00.
Rollins (ROL) — Citigroup maintained its Underperform rating.
RPM International (RPM) — Wells Fargo maintained its Overweight rating and lowered its price target to $130.00 from $135.00.
RXO (RXO) — Jefferies downgraded its rating to Hold from Buy.
RXO (RXO) — TD Cowen upgraded its rating to Hold from Sell.
Ryder System (R) — JPMorgan upgraded its rating to Overweight from Neutral and raised its price target to $298.00 from $296.00.
Ryder System (R) — Morgan Stanley upgraded its rating to Buy from Overweight.
S&P Global (SPGI) — Mizuho set a price target of $531.00.
Sable Offshore (SOC) — William Blair initiated coverage with an Outperform rating.
Sagimet Biosciences (SGMT) — H.C. Wainwright maintained its Buy rating with a $29.00 price target.
Saia (SAIA) — JPMorgan maintained its Overweight rating and lowered its price target to $463.00 from $490.00.
SailPoint (SAIL) — Scotiabank maintained its Sector Outperform rating and raised its price target to $24.00 from $22.00.
Samsara (IOT) — Jefferies initiated coverage with a Buy rating and a $50.00 price target.
Sarepta Therapeutics (SRPT) — H.C. Wainwright maintained its Sell rating with a $5.00 price target.
SBA Communications (SBAC) — Raymond James maintained its Outperform rating with a $271.00 price target.
Schneider National (SNDR) — JPMorgan maintained its Neutral rating and lowered its price target to $30.00 from $35.00.
Scotts Miracle-Gro (SMG) — Wells Fargo maintained its Overweight rating and lowered its price target to $60.00 from $77.00.
Semtech (SMTC) — Stifel maintained its Buy rating and raised its price target to $220.00 from $188.00.
Shell (SHEL) — Barclays maintained its Overweight rating.
Sherwin-Williams (SHW) — UBS maintained its Neutral rating and lowered its price target to $363.00 from $390.00.
Shift4 Payments (FOUR) — Susquehanna maintained its Positive rating and lowered its price target to $63.00 from $78.00.
Shopify (SHOP) — Piper Sandler maintained its Overweight rating.
Sight Sciences (SGHT) — Citigroup maintained its Neutral rating.
Silgan (SLGN) — UBS maintained its Neutral rating and lowered its price target to $38.00 from $47.00.
Silver Standard Resources (SSRM) — CIBC maintained its Outperformer rating and raised its price target to $50.00 from $48.00.
Solstice Advanced Mat (SOLS) — UBS maintained its Buy rating and lowered its price target to $76.00 from $80.00.
Sonic Automotive (SAH) — Morgan Stanley maintained its Underweight rating and lowered its price target to $57.00 from $72.00.
Sonoco Products (SON) — UBS maintained its Neutral rating and lowered its price target to $51.00 from $61.00.
Southern Missouri Bancorp (SMBC) — Hovde Group initiated coverage with a Market Perform rating and a $76.00 price target.
SouthState Bank (SSB) — Barclays maintained its Overweight rating and raised its price target to $120.00 from $118.00.
SouthState Bank (SSB) — TD Cowen maintained its Buy rating and lowered its price target to $116.00 from $120.00.
Southwest Gas (SWX) — Jefferies maintained its Buy rating with a $106.00 price target.
Spectrum Brands (SPB) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $85.00 from $90.00.
Sphere Entertainment (SPHR) — Craig-Hallum downgraded its rating to Hold from Buy with a $132.00 price target.
Spotify Technology (SPOT) — UBS maintained its Buy rating and lowered its price target to $675.00 from $690.00.
SPX Technologies (SPXC) — Baird set a price target of $220.00.
SPX Technologies (SPXC) — Truist Securities maintained its Buy rating and lowered its price target to $266.00 from $301.00.
Spyglass Pharma (SGP) — H.C. Wainwright maintained its Buy rating with a $37.00 price target.
Spyglass Pharma (SGP) — UBS maintained its Buy rating.
Stagwell (STGW) — Goldman Sachs resumed coverage with a Buy rating and a $13.00 price target.
State Street (STT) — Citigroup maintained its Buy rating and raised its price target to $212.00 from $210.00.
Strategic Education (STRA) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $95.00 from $100.00.
Stride (LRN) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $90.00 from $93.00.
Summit Therapeutics (SMMT) — Sanford C. Bernstein maintained its Market Perform rating.
Swatch Group (SWGAY) — Goldman Sachs initiated coverage with a Sell rating.
Synchrony Financial (SYF) — UBS maintained its Neutral rating and lowered its price target to $81.00 from $87.00.
T1 Energy (TE) — Northland Securities set a price target of $9.00.
Tenaris (TS) — BofA Securities maintained its Buy rating and raised its price target to $71.00 from $66.00.
Terex (TEX) — Truist Securities maintained its Buy rating and lowered its price target to $85.00 from $96.00.
Tesla (TSLA) — Goldman Sachs upgraded its rating to Buy from Neutral.
Tesla (TSLA) — HSBC maintained its Reduce rating with a $157.00 price target.
Texas Capital Bancshares (TCBI) — TD Cowen maintained its Hold rating and lowered its price target to $100.00 from $106.00.
Texas Roadhouse (TXRH) — Evercore ISI upgraded its rating to Outperform from In-Line with a $200.00 price target.
Texas Roadhouse (TXRH) — RBC Capital Markets maintained its Outperform rating and lowered its price target to $220.00 from $235.00.
TFI International (TFII) — CIBC maintained its Outperformer rating and lowered its price target to $158.00 from $175.00.
TFI International (TFII) — JPMorgan maintained its Overweight rating and lowered its price target to $168.00 from $175.00.
The Goldman Sachs Group (GS) — UBS maintained its Neutral rating and lowered its price target to $1,010.00 from $1,150.00.
The PNC Financial Services Group (PNC) — Goldman Sachs maintained its Neutral rating and lowered its price target to $250.00 from $281.00.
Tilray Brands (TLRY) — TD maintained its Buy rating and lowered its price target to $4.50 from $4.70.
TotalEnergies (TTE) — Barclays maintained its Overweight rating.
Tronox (TROX) — UBS maintained its Neutral rating and lowered its price target to $4.50 from $7.00.
Truist Financial (TFC) — UBS maintained its Neutral rating and lowered its price target to $50.00 from $55.00.
U.S. Bancorp (USB) — UBS maintained its Neutral rating and lowered its price target to $64.00 from $66.00.
Uber Technologies (UBER) — Wells Fargo maintained its Overweight rating and raised its price target to $92.00 from $89.00.
Ultra Clean (UCTT) — UBS maintained its Buy rating with a $135.00 price target.
UMB Financial (UMBF) — TD Cowen maintained its Buy rating and lowered its price target to $152.00 from $166.00.
Union Pacific (UNP) — JPMorgan maintained its Neutral rating and lowered its price target to $322.00 from $334.00.
uniQure (QURE) — Barclays downgraded its rating to Equal Weight from Overweight and lowered its price target to $28.00 from $60.00.
United Rentals (URI) — Truist Securities maintained its Buy rating and lowered its price target to $1,395.00 from $1,466.00.
Unity Software (U) — Piper Sandler maintained its Overweight rating.
Valaris (VAL) — Susquehanna maintained its Neutral rating and raised its price target to $86.00 from $80.00.
Vanda Pharmaceuticals (VNDA) — H.C. Wainwright maintained its Buy rating with a $20.00 price target.
Vaxcyte (PCVX) — BTIG maintained its Buy rating with a $89.00 price target.
Vaxcyte (PCVX) — Guggenheim maintained its Buy rating and raised its price target to $125.00 from $116.00.
Vaxcyte (PCVX) — Needham maintained its Buy rating and raised its price target to $122.00 from $110.00.
Veralto (VLTO) — UBS maintained its Neutral rating and raised its price target to $106.00 from $104.00.
Verastem (VSTM) — BTIG maintained its Buy rating with a $18.00 price target.
Verastem (VSTM) — H.C. Wainwright maintained its Buy rating with a $18.00 price target.
Vertiv (VRT) — BMO Capital Markets initiated coverage with an Outperform rating and a $329.00 price target.
Viatris (VTRS) — UBS maintained its Buy rating and raised its price target to $26.00 from $23.00.
Virtu Financial (VIRT) — Evercore ISI upgraded its rating to Outperform.
Virtu Financial (VIRT) — JPMorgan upgraded its rating to Overweight from Neutral with a $84.00 price target.
Vistra (VST) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $210.00 from $231.00.
Vita Coco (COCO) — Wells Fargo maintained its Overweight rating and lowered its price target to $65.00 from $85.00.
Vulcan Materials (VMC) — Truist Securities maintained its Buy rating and lowered its price target to $320.00 from $360.00.
Vulcan Materials (VMC) — Wells Fargo maintained its Underweight rating and lowered its price target to $249.00 from $254.00.
Vylor (VYLR) — BofA Securities initiated coverage with a Buy rating and a $78.00 price target.
Vylor (VYLR) — Mizuho initiated coverage with an Outperform rating and a $84.00 price target.
Vylor (VYLR) — Vertical Research initiated coverage with a Buy rating and a $74.00 price target.
Walt Disney (DIS) — Raymond James maintained its Outperform rating and lowered its price target to $119.00 from $120.00.
Wells Fargo & Company (WFC) — Goldman Sachs maintained its Buy rating and lowered its price target to $96.00 from $107.00.
Wells Fargo & Company (WFC) — Morgan Stanley upgraded its rating to Overweight from Equal Weight with a $102.00 price target.
Wells Fargo & Company (WFC) — UBS maintained its Buy rating and lowered its price target to $102.00 from $104.00.
Werner Enterprises (WERN) — JPMorgan maintained its Underweight rating and lowered its price target to $33.00 from $39.00.
Western Alliance Bancorporation (WAL) — Barclays maintained its Overweight rating and raised its price target to $93.00 from $88.00.
Western Alliance Bancorporation (WAL) — TD Cowen maintained its Hold rating and lowered its price target to $85.00 from $90.00.
Westlake (WLK) — Citigroup maintained its Neutral rating and lowered its price target to $67.00 from $85.00.
Westlake (WLK) — UBS maintained its Buy rating and lowered its price target to $86.00 from $98.00.
Weyerhaeuser (WY) — Citigroup maintained its Buy rating and lowered its price target to $21.00 from $29.00.
Wintrust Financial (WTFC) — Barclays maintained its Overweight rating and lowered its price target to $190.00 from $192.00.
Wintrust Financial (WTFC) — Piper Sandler maintained its Overweight rating and raised its price target to $195.00 from $186.00.
Wintrust Financial (WTFC) — TD Cowen maintained its Buy rating and lowered its price target to $173.00 from $183.00.
Workday (WDAY) — Needham maintained its Buy rating with a $230.00 price target.
WSFS Financial (WSFS) — TD Cowen maintained its Buy rating and lowered its price target to $89.00 from $92.00.
XPO (XPO) — JPMorgan maintained its Overweight rating and lowered its price target to $205.00 from $214.00.
Xylem (XYL) — UBS maintained its Neutral rating and lowered its price target to $112.00 from $138.00.
Yesway (YSWY) — Guggenheim maintained its Buy rating with a $32.00 price target.
Zebra Technologies (ZBRA) — Truist Securities maintained its Hold rating and raised its price target to $378.00 from $355.00.
Zentalis Pharmaceuticals (ZNTL) — Leerink Partners resumed coverage with an Outperform rating and raised its price target to $8.00 from $4.00.
Zeta Global (ZETA) — RBC Capital Markets maintained its Outperform rating and raised its price target to $40.00 from $31.00.
Zimmer Biomet (ZBH) — Citigroup maintained its Neutral rating.
Zions Bancorporation, N.A. (ZION) — TD Cowen maintained its Hold rating and lowered its price target to $69.00 from $73.00.
Zscaler (ZS) — Scotiabank maintained its Sector Outperform rating and raised its price target to $240.00 from $200.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.